Skip to main content

Tempest Therapeutics, Inc 8-K, filed Nov 13, 2026

Tempest Therapeutics, Inc. (TPST)

8-K 2026-11-13 For: 2026-11-13
View Original
Added on November 13, 2026

About this 8-K

Tempest Therapeutics, Inc filed this 8-K on November 13, 2026.

Tempest Therapeutics reported $0.9 million in cash, substantial doubt about continuing as a going concern and expected funding for less than 12 months. It licensed TPST-4903 and secured an equity line of credit of up to $50.0 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits